Hangzhou-based Chinese e-commerce giant Alibaba Group has acquired 54% in Chinese pharmaceutical data firm CITIC 21CN for around HK$1.3 billion (US$170 million), according to a security filing.
Subscribe & Access the Best Data and Intelligence on Chinese Venture Capital and Tech
Want to read this important story?
Access Over 11,000 stories and data posts over the past 8 years!Register Now
Already have an account or paid subscription?